REGENSTRIEF INSTITUTE One of the first real-world data studies comparing the new bivalent mRNA COVID-19 booster vaccines with the original monovalent vaccines reports the bivalent conveyed greater short-term protection against symptomatic COVID-19 infection in adults. The multi-state study from the Centers for Disease Control and Prevention’s VISION Network found that the bivalent booster dose provides greater...